Enhanced Nanoparticles for Targeted Antibiotic Delivery

The present inventive concept discloses improved nanoparticles for antibiotic delivery, offering enhanced stability, controlled release, and targeted action against specific bacteria, thereby addressing the growing concern of antibiotic resistance.

The original patent, 'Nanoparticles carrying antibiotics', described a method for producing aqueous emulsions of nanoparticles for antibacterial compounds. However, the existing patent has limitations, including aggregation, poor bioavailability, and lack of targeted action. The present inventive concept addresses these limitations by introducing novel modifications to the nanoparticles, resulting in enhanced stability, controlled release, and targeted delivery of antibiotics.

The inventive concept comprises nanoparticles modified with hydrophilic polymers to reduce aggregation and improve bioavailability. The nanoparticles are designed to target specific bacteria and release antibiotics in a sustained manner. Additionally, the nanoparticles may be coated with a layer of polyethylene glycol to reduce immunogenicity and improve circulation time. The inventive concept also includes a process for preparing antibiotic-loaded nanoparticles using a microfluidic device, ensuring uniformity and reducing batch-to-batch variation. Furthermore, the nanoparticles may be designed to respond to changes in pH or temperature to release antibiotics in a targeted manner.

The present inventive concept introduces novel modifications to the nanoparticles, including the use of hydrophilic polymers, polyethylene glycol coating, and microfluidic device-based preparation. These modifications provide enhanced stability, controlled release, and targeted action, which are not obvious from the original patent.

Alternative embodiments of the inventive concept may include the use of different hydrophilic polymers, varying the thickness of the polyethylene glycol coating, or employing different microfluidic device designs. Additionally, the nanoparticles may be designed to respond to different environmental stimuli, such as changes in pH, temperature, or light.

The present inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the development of targeted antibiotic delivery systems. The inventive concept may be applied in various industries, including human healthcare, veterinary medicine, and agricultural applications, addressing the growing concern of antibiotic resistance.